GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,114,000 | -14.8% | 48,547 | -14.8% | 0.00% | 0.0% |
Q1 2022 | $2,482,000 | -1.9% | 56,966 | -4.3% | 0.00% | 0.0% |
Q4 2021 | $2,531,000 | +18.5% | 59,507 | +5.4% | 0.00% | 0.0% |
Q3 2021 | $2,136,000 | -8.8% | 56,447 | -4.9% | 0.00% | 0.0% |
Q2 2021 | $2,342,000 | +13.1% | 59,328 | +2.2% | 0.00% | 0.0% |
Q1 2021 | $2,071,000 | +19.4% | 58,036 | +23.2% | 0.00% | 0.0% |
Q4 2020 | $1,734,000 | -55.5% | 47,113 | -54.5% | 0.00% | -60.0% |
Q3 2020 | $3,898,000 | -8.2% | 103,550 | -0.3% | 0.01% | 0.0% |
Q2 2020 | $4,248,000 | -14.5% | 103,901 | -20.6% | 0.01% | -37.5% |
Q1 2020 | $4,967,000 | -68.6% | 130,813 | -61.1% | 0.01% | -55.6% |
Q4 2019 | $15,825,000 | +171.4% | 336,569 | +146.4% | 0.02% | +157.1% |
Q3 2019 | $5,831,000 | +2.4% | 136,621 | -3.9% | 0.01% | 0.0% |
Q2 2019 | $5,692,000 | -6.9% | 142,212 | -2.8% | 0.01% | 0.0% |
Q1 2019 | $6,116,000 | +19.4% | 146,353 | +9.2% | 0.01% | 0.0% |
Q4 2018 | $5,121,000 | -7.0% | 134,033 | -2.2% | 0.01% | +16.7% |
Q3 2018 | $5,506,000 | -16.8% | 137,087 | -16.5% | 0.01% | -14.3% |
Q2 2018 | $6,618,000 | +0.4% | 164,179 | -2.7% | 0.01% | -12.5% |
Q1 2018 | $6,594,000 | +20.7% | 168,778 | +9.6% | 0.01% | +33.3% |
Q4 2017 | $5,462,000 | -86.4% | 153,989 | -84.5% | 0.01% | -88.0% |
Q3 2017 | $40,262,000 | -4.3% | 991,683 | +1.6% | 0.05% | -7.4% |
Q2 2017 | $42,086,000 | +2.7% | 976,023 | +0.4% | 0.05% | +1.9% |
Q1 2017 | $40,971,000 | +63.0% | 971,788 | +48.9% | 0.05% | +55.9% |
Q4 2016 | $25,136,000 | -61.3% | 652,724 | -56.7% | 0.03% | -61.4% |
Q3 2016 | $64,997,000 | -0.6% | 1,506,999 | -0.1% | 0.09% | -2.2% |
Q2 2016 | $65,411,000 | +1.1% | 1,509,256 | -5.4% | 0.09% | +1.1% |
Q1 2016 | $64,685,000 | +21.3% | 1,595,190 | +20.7% | 0.09% | +27.1% |
Q4 2015 | $53,309,000 | -7.2% | 1,321,155 | -11.6% | 0.07% | -5.4% |
Q3 2015 | $57,442,000 | +0.9% | 1,493,943 | +9.3% | 0.07% | +17.5% |
Q2 2015 | $56,944,000 | +6.5% | 1,367,194 | +18.0% | 0.06% | +10.5% |
Q1 2015 | $53,452,000 | +49.3% | 1,158,226 | +38.2% | 0.06% | +54.1% |
Q4 2014 | $35,813,000 | +26.2% | 837,944 | +35.7% | 0.04% | +27.6% |
Q3 2014 | $28,387,000 | +215.4% | 617,521 | +266.9% | 0.03% | +222.2% |
Q2 2014 | $9,000,000 | -1.5% | 168,289 | -1.6% | 0.01% | 0.0% |
Q1 2014 | $9,140,000 | -4.7% | 171,068 | -4.7% | 0.01% | -10.0% |
Q4 2013 | $9,587,000 | -51.1% | 179,566 | -56.1% | 0.01% | -16.7% |
Q3 2013 | $19,601,000 | +105.2% | 409,394 | +114.1% | 0.01% | +9.1% |
Q2 2013 | $9,553,000 | – | 191,175 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |